Diabetes Mellitus and Health Services: Access Gap During the COVID-19 Pandemic
Abstract
Abstract: Diabetes Mellitus is a significant health problem worldwide and its prevalence is increasing yearly. This fact is coupled with the problem of the discovery of a new virus known as SARS-CoV-2 or COVID-19. Many questions have been asked, starting from how to treat patients with diabetes and their access to treatment. As a disease with a high risk of complications, integrated diabetes health care is still underdeveloped. For this reason, it is necessary to search to see what gaps exist in the use of telemedicine-based health services so that themes of these discrepancies can be identified. This study uses the method of searching and reviewing 24 kinds of literature. There were gaps in access and health care for racial and ethnic minorities, Obstacles faced in the diagnosis of Diabetes, Obstacles to patients in self-monitoring of blood sugar, Gaps in providing care due to COVID-19, Gaps in access to diabetes drugs, insulin, SGLT2 in Type 2 Diabetes patients, Gaps in access to care for type 2 diabetes patients with cardiovascular disease, use in access to diabetes care, and using telemedicine. It is necessary to develop a healthcare strategy for patients with Diabetes, including the team, then glycaemic and control targets, as well as patient preferences and priorities.
Keywords
Full Text:
PDFReferences
Noor N, Ebekozien O, Levin L, Stone S, Sparling DP, Rapaport R, et al. Diabetes technology used for the management of type 1 diabetes is associated with fewer adverse COVID-19 outcomes: findings from the t1d exchange COVID-19 surveillance registry. Diabetes Care. 2021;44(8):e160–2.
Nguyen NH, Subhan FB, Williams K, Chan CB. Barriers and mitigating strategies to healthcare access in indigenous communities of Canada: A narrative review. Healthc. 2020;8(2):1–16.
Aberer F, Hochfellner DA, Mader JK. Application of telemedicine in diabetes care: the time is now. diabetes the [Internet]. 2021;12(3):629–39. Available from: https://doi.org/10.1007/s13300-020-00996-7
Scalzo P. From the association of diabetes care & education specialists: the role of the diabetes care and education specialist as a Champion of technology integration. Sci Diabetes Self-Management Care. 2021;47(2):120–3.
Falcetta P, Aragona M, Ciccarone A, Bertolotto A, Campi F, Coppelli A, et al. Impact of COVID-19 lockdown on glucose control of elderly people with Type 2 diabetes in Italy. Diabetes Res Clin Pract [Internet]. 2021;174:108750. Available from: https://doi.org/10.1016/j.diabres.2021.108750
Morton JI, Ilomӓki J, Magliano DJ, Shaw JE. The association of socioeconomic disadvantage and remoteness with receipt of type 2 diabetes medications in australia: a nationwide registry study. Diabetologia. 2021;64(2):349–60.
Rattelman CR, Ciemins EL, Stempniewicz N, Mocarski M, Ganguly R, Cuddeback JK. A retrospective analysis of therapeutic inertia in type 2 diabetes management across a diverse population of health care organizations in the USA. Diabetes Ther [Internet]. 2021;12(2):581–94. Available from: https://doi.org/10.1007/s13300-020-00993-w
Campbell RB, Larsen M, DiGiandomenico A, Davidson MA, Booth GL, Hwang SW, et al. The challenges of managing diabetes while homeless: a qualitative study using the photovoice methodology. Cmaj. 2021;193(27):E1034–41.
Alessi J, de Oliveira GB, Franco DW, Becker AS, Knijnik CP, Kobe GL, et al. Telehealth strategy to mitigate the negative psychological impact of the COVID-19 pandemic on type 2 diabetes: A randomized controlled trial. Acta Diabetol [Internet]. 2021;58(7):899–909. Available from: https://doi.org/10.1007/s00592-021-01690-1
Siegel KR, Gregg EW, Duru OK, Shi L, Mangione CM, Thornton PL, et al. Time to start addressing (and not just describing) the social determinants of diabetes: Results from the NEXT-D 2.0 network. BMJ Open Diabetes Res Care. 2021;9:1–5.
Lemon SM, Walker CM. 乳鼠心肌提取 HHS Public Access. Physiol Behav. 2019;19(5):1–12.
Abd-alrazaq AA, Suleiman N, Baagar K, Jandali N, Alhuwail D, Abdalhakam I, et al. Patients and healthcare workers' experience with a mobile application for self-management of diabetes in Qatar: A qualitative study. Comput Methods Programs Biomed Updat [Internet]. 2021;1(December 2020):100002. Available from: https://doi.org/10.1016/j.cmpbup.2021.100002
Majidi S, Ebekozien O, Noor N, Lyons SK, McDonough R, Gandhi K, et al. Inequities in health outcomes in children and adults with type 1 diabetes: Data from the T1D exchange quality improvement collaborative. Clin Diabetes. 2021;39(3):278–83.
Ruissen MM, Regeer H, Landstra CP, Schroijen M, Jazet I, Nijhoff MF, et al. Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic. BMJ Open Diabetes Res Care. 2021;9(1):1–7.
Eberly LA, Yang L, Eneanya ND, Essien U, Julien H, Nathan AS, et al. Association of race/ethnicity, gender, and socioeconomic status with sodium-glucose cotransporter 2 inhibitor use among patients with diabetes in the US. JAMA Netw Open. 2021;4(4):1–13.
Lee CW, Wu SH, Chiu WC, Tsai ST, Lan TY. The medications and health care utilization of patients newly diagnosed with type 2 diabetes mellitus: A nationwide population-based cohort study. J Formos Med Assoc [Internet]. 2021;120(1):130–6. Available from: https://doi.org/10.1016/j.jfma.2020.03.001
Tejera- Perez C, Moreno-Pérez Ó, Rios J, Reyes-García R. People living with type 1 diabetes point of view in COVID-19 times (COVIDT1 study): Disease impact, health system pitfalls and lessons for the future. Diabetes Res Clin Pract. 2021;171:1–8.
Stempniewicz N, Vassalotti JA, Cuddeback JK, Ciemins E, Storfer-Isser A, Sang Y, et al. Chronic kidney disease testing among primary care patients with type 2 diabetes across 24 U.S. health care organizations. Diabetes Care. 2021;44(9):2000–9.
Pranata S, Wu SFV, Alizargar J, Liu JH, Liang SY, Lu YY. Precision health care elements, definitions, and strategies for patients with diabetes: A literature review. Int J Environ Res Public Health. 2021;18(12).
Lombardo F, Salzano G, Bombaci B, Basile P, Lucania G, Alibrandi A, et al. Has COVID-19 lockdown improved glycaemic control in pediatric patients with type 1 diabetes? An analysis of continuous glucose monitoring metrics. Diabetes Res Clin Pract [Internet]. 2021;178:108988. Available from: https://doi.org/10.1016/j.diabres.2021.108988
Kamaldeep, Roy S, Poonia RC, Nayak SR, Kumar R, Alzahrani KJ, et al. Evaluating the usability of health applications on type 2 diabetes mellitus using various mcdm models. Healthc. 2022;10(1).
Sujan MSH, Tasnim R, Islam MS, Ferdous MZ, Apu MAR, Musfique MM, et al. COVID-19-specific diabetes worries amongst diabetic patients: The role of social support and other co-variates. Prim Care Diabetes [Internet]. 2021;15(5):778–85. Available from: https://doi.org/10.1016/j.pcd.2021.06.009
Ogunwole SM, Golden SH. Social determinants of health and structural inequitiesdroot causes of diabetes disparities. Diabetes Care. 2021;44(1):11–3.
Chevance A, Gourion D, Hoertel N, Llorca P, Thomas P, Bocher R. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information. Elsevier Masson Fr. 2020;46(January):193–201.
DOI: https://doi.org/10.30596/bf.v8i2.12662
DOI (PDF): https://doi.org/10.30596/bf.v8i2.12662.g9778
Refbacks
- There are currently no refbacks.
JURNAL BULETIN FARMATERA
Gedung Kampus 1 Universitas Muhammadiyah Sumatera Utara (UMSU) Lantai II, Laboratorium Farmakologi dan Terapi Fakultas Kedokteran UMSU Jalan Gedung Arca No. 53 Medan Sumatera Utara Indonesia, Kode Pos 20217.
Contact (WA): 0812-6208-2844
E-mail: farmatera@umsu.ac.id
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.